Recombinant DNA Advisory Committee - 09/9-10/93 
qualifications of any new investigators, (2) a summary of approved accelerated review 
protocols would be presented to the full committee at scheduled RAC meetings, and (3) 
semi-annual data reports would be required for all accelerated review protocols in order 
to monitor for evidence of gene transfer and possible adverse effects. 
Dr. Walters proposed that the working group continue to refine the criteria for 
accelerated review protocols and to develop draft language for inclusion in the NIH 
Guidelines. This material will be reviewed by the full RAC at its December 1993 
meeting. The RAC will also reconsider the definition of recombinant DNA vaccines 
with the view that Footnote 21 in Section V of the NIH Guidelines may need to be 
XVIII. FUTURE MEETINGS OF THE RAC 
Dr. Walters announced that the next meeting of the RAC will be December 2-3, 1993, 
NIH, Building 3 1C, Conference Room 6. 
XIX. ADJOURNMENT 
Dr. Walters adjourned the meeting at 3:30 p.m. on September 10, 1993. 
revised. 
Nelson A Wivei, M.D. 
Executive Secretary 
I hereby acknowledge that, to the best of my 
knowledge, the foregoing Minutes and Attach- 
ments are accurate and complete. 
Date: 
L Valters, Ph.D. 
v2. 
Chair 
Recombinant DNA Advisory Committee 
National Institutes of Health 
[ 220 ] 
Recombinant DNA Research, Volume 18 
